Dysferlin is a plasma membrane protein and is expressed early in human development

Human Molecular Genetics

Volumn 8, Issue 5, 1999, Pages 855-861

  Anderson, Louise V B ^a   Davison, Keith ^a   Moss, Jennifer A ^a   Young, Carol ^a   Cullen, Michael J ^a   Walsh, John ^a   Johnson, Margaret A ^a   Bashir, Rumaisa ^b   Britton, Stephen ^b   Keers, Sharon ^b   Argov, Zohar ^c   Mahjneh, Ibrahim ^d   Fougerousse, Françoise ^e   Beckmann, Jacques S ^e   Bushby, Kate M D ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d KAINUU CENTRAL HOSPITAL   (Finland)

^e GÉNÉTHON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANE PROTEIN; DYSFERLIN; DYSTROPHIN; GENE PRODUCT; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MUSCLE PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY LABELING; ARTICLE; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; FETUS; FETUS DEVELOPMENT; FRAMESHIFT MUTATION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; LIMB GIRDLE MUSCULAR DYSTROPHY; MIYOSHI MYOPATHY; MOLECULAR WEIGHT; MUSCLE; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SKELETAL MUSCLE; TISSUE DIFFERENTIATION;

EID: 0032955751     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/8.5.855     Document Type: Article

References (40)

1. Brown, R.H. (1997) Dystrophin-associated proteins and the muscular dystrophies. Annu. Rev. Med., 48, 457-466.
2. Noguchi, S., McNally, E.M., Othmane, K.B., Hagiwara, Y., Mizuno, Y., Yoshida, M., Yamanmoto, H., Bönnemann, C.G., Gussoni, E., Denton, P.H., Kyriakides, T., Middleton, L., Hentati, F., Hamida, M.B., Nonaka, I., Vance, J.M., Kunkel, L.M. and Ozawa, E. (1995) Mutations in the dystrophin-associated protein-γ-sarcoglycan in chromosome 13 muscular dystrophy. Science, 270, 819-822.
3. Roberds, S.L., Leturcq, F., Allamand, V., Piccolo, F., Jeanpierre, M., Anderson, R.D., Lim, L.E., Lee, J.C., Tomé, F.M.S., Romero, N.B., Fardeau, M., Beckmann, J.S., Kaplan, J.-C. and Campbell, K.P. (1994) Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell, 78, 625-633.
4. Lim, L.E., Duclos, F., Broux, O., Bourg, N., Sanada, Y., Allamand, V., Meyer, J., Richard, I., Moomaw, C., Slaughter, C., Tomé, F.M.S., Fardeau, M., Jackson, C.E., Beckmann, J.S. and Campbell, K.P. (1995) β-Sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nature Genet., 11, 257-265.
5. Nigro, V., de Sá Moreira, E., Piluso, G., Vainzof, M., Belsito, A., Politano, L., Puca, A.A., Passos-Bueno, M.R. and Zatz, M. (1996) Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the δ-sarcoglycan gene. Nature Genet., 14, 195-198.
6. Richard, I., Broux, O., Allamand, V., Fougerousse, F., Chiannilkulchai, N., Bourg, N., Brenguier, L., Devaud, C., Pasturaud, P., Roudaut, C., Hillaire, D., Passos-Bueno, M.R., Zatz, M., Tischfield, J.A., Fardeau, M., Jackson, C.E., Cohen, D. and Beckmann, J.S. (1995) Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell, 81, 27-40.
7. Bashir, R., Britton, S., Strachan, T., Keers, S., Vafiadaki, E., Lako, M., Richard, I., Marchand, S., Bourg, N., Argov, Z., Sadeh, S., Mahjneh, I., Marconi, G., Passos-Bueno, M.R., de Sá Moreira, E., Zatz, M., Beckmann, J.S. and Bushby, K.M.D. (1998) A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nature Genet., 20, 37-42.
8. Liu, J., Aoki, M., Illa, I., Chenyan, W., Fardeau, M., Angelini, C., Serrano, C., Urtizberea, J.A., Hentati, F., Hamida, M.B., Bohlega, S., Culper, E.J., Amato, A.A., Bossie, K., Oeltjen, J., Bejaoui, K., McKenna-Yasek, D., Hosler, B.A., Schurr, E., Arahata, K., de Jong, P.J. and Brown, R.H. (1998) Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nature Genet., 20, 31-36.
9. Moreira, E.S., Vainzof, M., Marie, S.K., Sertié, A.L., Zatz, M. and Passos-Bueno, M.R. (1997) The seventh form of autosomal recessive limb-girdle muscular dystrophy is mapped to 17q11-12. Am. J. Hum. Genet., 61, 151-159.
10. Weiler, T., Greenberg, C.R., Zelinski, T., Nylen, E., Coghlan, G., Crumley, M.J., Fujiwara, T.M., Morgan, K. and Wrogemann, K. (1998) A gene for autosomal recessive limb-girdle muscular dystrophy in Manitoba Hutterites maps to chromosome region 9q31-q33: evidence for another limb-girdle muscular dystrophy locus. Am. J. Hum. Genet., 63, 140-147.
11. Bushby, K.M.D., Anderson, L.V.B., Pollitt, C., Naom, I., Muntoni, F. and Bindoff, L. (1998) Abnormal merosin in adults - a new form of late onset muscular dystrophy not linked to chromosome 6q2. Brain, 121, 581-588.
12. Nicholson, L.V.B., Johnson, M.A., Gardner-Medwin, D., Bhattacharya, S. and Harris, J.B. (1990) Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy. Acta Neuropathol., 80, 239-250.
13. Nicholson, L.V.B., Johnson, M.A., Bushby, K.M.D., Gardner-Medwin, D., Curtis, A., Ginjaar, H.B., den Dunnen, J.T., Welch, J.L., Butler, T.J., Bakker, E., van Ommen, G.-J.B. and Harris, J.B. (1993) (Trilogy) Integrated study of 100 patients with Xp21-linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1 Trends across the clinical groups. Part 2 Correlations within individual patients. Part 3 Differential diagnosis and prognosis. J. Med. Genet., 30, 728-736, 737-744, 745-751.
14. Fanin, M., Danieli, G.A., Vitiello, L., Senter, L. and Angelini, C. (1992) Prevalence of dystrophin-positive fibers in 85 Duchenne muscular dystrophy patients. Neuromusc. Disord., 2, 41-45.
15. Weiler, T., Bashir, R., Anderson, L.V.B., Davison, K., Moss, J.A., Britton, S., Nylen, E., Keers, S., Vafiadaki, E., Greenberg, C.R., Bushby, K.M.D. and Wrogemarm, K. (1999) Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s). Hum. Mol. Genet., 8, 871-877.
16. Tennyson, C.N., Klamut, H.J. and Worton, R.G. (1995) The human dystrophin gene requires 16 hours to be transcribed and is contranscripturally spliced. Nature Genet., 9, 184-190.
17. Nicholson, L.V.B., Davison, K., Falkous, G., Harwood, C., O'Donnell, E., Slater, C.R. and Harris, J.B. (1989) Dystrophin in skeletal muscle: I. Western blot analysis using a monoclonal antibody. J. Neurol. Sci., 94, 125-136.
18. Hoffman, E.P., Brown, R.H. and Kunkel, L.M. (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell, 51, 919-928.
19. Bönnemann, C.G., Modi, R., Noguchi, S., Mizuno, Y., Yoshida, M., Gussoni, E., McNally, E.M., Duggan, D.J., Angelini, C., Hoffman, E.P., Ozawa, E. and Kunkel, L.M. (1995) β-Sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nature Genet., 11, 266-273.
20. Helbling-Leclerc, A., Zhang, X., Topaloglu, H., Cruaud, C., Tesson, F., Weissenbach, J., Tóme, F.M.S., Schwartz, K., Fardeau, M., Tryggvason, K. and Guicheney, P. (1995) Mutations in the laminin α2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nature Genet., 11, 216-218.
21. Hayashi, Y.K., Chou, F.L., Engvall, E., Ogawa, M., Matsuda, C., Hirabayashi, S., Yokochi, K., Ziober, B.L., Kramer, R.H., Kaufman, S.J., Ozawa, E., Goto, Y., Nonaka, I., Tsukahara, T., Wang, J.Z., Hoffman, E.P. and Arahata, K. (1998) Mutations in the integrin α7 gene cause congenital myopathy. Nature Genet., 19, 94-97.
22. Minetti, C., Sotgia, F., Bruno, P., Scartezzini, P., Broda, P., Bado, M., Masetti, E., Mazzocco, M., Egeo, A., Donati, M.A., Volonté, D., Galbiati, F., Cordone, G., Bricarelli, F.D., Lisanti, M.P. and Zara, F. (1998) Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nature Genet., 18, 365-368.
23. Fougerousse, F., Durand, M., Suel, L., Pourquié, O., Delezoide, A.-L., Romero, N.B., Abitbol, M. and Beckmann, J.S. (1998) Expression of genes (CAPN3, SGCA, SGCB, and TTN) involved in progressive muscular dystrophies during early human development. Genomics, 48, 145-156.
24. Passos-Bueno, M.R., de Sá Moreira, E., Marie, S.K., Bashir, R., Vasquez, L., Love, D.R., Vainzof, M., Lughetti, P., Oliveira, J.R., Bakker, E., Strachan, T., Bushby, K.M.D. and Zatz, M. (1996) Main clinical features for the three mapped autosomal recessive limb-girdle muscular dystrophies and estimated proportion of each form in 13 Brazilian families. J. Med. Genet., 33, 97-102.
25. Nicholson, L.V.B. (1993) The 'rescue' of dystrophin synthesis in boys with Duchenne muscular dystrophy. Neuromusc. Disord., 3, 525-532.
26. Thanh, L.T., Nguyen thi Man, Helliwell, T.R. and Morris, G.E. (1995) Characterization of revertant muscle fibers in Duchenne muscular dystrophy, using exon specific monoclonal antibodies against dystrophin. Am. J. Hum. Genet., 56, 725-731.
27. Shiga, N., Takeshima, Y., Sakamoto, H., Inoue, K., Yokota, Y., Yokoyama, M. and Matsuo, M. (1997) Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy. J. Clin. Invest., 100, 2204-2210.
28. Wilton, S.D., Dye, D.E., Blechynden, L.M. and Laing, N.G. (1997) Revertant fibres: a possible genetic therapy for Duchenne muscular dystrophy? Neuromusc. Disord., 7, 329-335.
29. Schatzberg, S.J., Anderson, L.V.B., Wilton, S.D., Kornegay, J.N., Mann, C.J., Solomon, G.G. and Sharp, N.J.H. (1998) Alternative dystrophin gene transcripts in golden retriever muscular dystrophy. Muscle Nerve, 21, 991-998.
30. Mahjneh, I., Passos-Bueno, M.R., Zatz, M., Vainzof, M., Marconi, G., Nashef, L., Bashir, R. and Bushby, K. (1996) The phenotype of chromosome 2p-linked limb-girdle muscular dystrophy. Neuromusc. Disord., 6, 483-490.
31. Weiler, T., Greenberg, C.R., Nylen, E., Halliday, W., Morgan, K., Eggertson, D. and Wrogemann, K. (1996) Limb-girdle muscular dystrophy and Miyoshi myopathy in an aboriginal Canadian kindred map to LGMD2B and segregate with the same haplotype. Am. J. Hum. Genet., 59, 872-878.
32. Linssen, W.H.J.P., Notermans, N.C., Van der Graaf, Y., Wokke, J.H.J., Van Doorn, P.A., Höweler, C.J., Busch, H.F.M., De Jager, A.E.J. and de Visser, M. (1997) Miyoshi-type distal muscular dystrophy - clinical spectrum in 24 Dutch patients. Brain, 120, 1989-1996.
33. Argov, Z., Mazor, K., Sadeh, M., Eisenberg, I., Mitrani-Rosenbaum, S. and Bashir, R. (1998) Cluster of limb-girdle muscular dystrophy (LGMD) 2B in Libyan Jews. Muscle Nerve, Suppl. 7, S134.
34. Cupler, E.J., Bohlega, S., Hessler, R., McLean, D., Stigsby, B. and Ahmad, J. (1998) Miyoshi myopathy in Saudi Arabia: clinical, electrophysiological, histopathological and radiological features. Neuromusc. Disord., 8, 321-326.
35. Emery, A.E.H. (1993) Duchenne Muscular Dystrophy. Oxford University Press, New York.
36. Kearney, J.F., Radbruch, A., Liesegang, B. and Rajewsky, K. (1979) A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J. Immunol., 123, 1548-1550.
37. Anderson, L.V.B., Davison, K., Moss, J.A., Richard, I., Fardeau, M., Tomé, F.M.S., Hübner, C., Lasa, A., Colomer, J. and Beckmann, J.S. (1998) Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A. Am. J. Pathol., 153, 1169-1179.
38. Nicholson, L.V.B., Davison, K., Johnson, M.A., Slater, C.R., Young, C., Bhattacharya, S., Gardner-Medwin, D. and Harris, J.B. (1989) Dystrophin in skeletal muscle: II. Immunoreactivity in patients with Xp21 muscular dystrophy. J. Neurol. Sci., 94, 137-146.
39. Cullen, M.J., Walsh, J., Nicholson, L.V.B. and Harris, J.B. (1990) Ultrastructural localization of dystrophin in human muscle by using gold immunolabelling. Proc. R. Soc. Lond. B, 240, 197-210.
40. Cullen, M.J., Walsh, J., Roberds, S.L. and Campbell, K.P. (1996) Ultrastructural localization of adhalin, β-dystroglycan and merosin in normal and dystrophic muscle. Neuropathol. Appl. Neurobiol., 22, 30-37.